Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 551.00
Bid: 550.00
Ask: 569.00
Change: 1.00 (0.18%)
Spread: 19.00 (3.455%)
Open: 545.00
High: 551.00
Low: 545.00
Prev. Close: 550.00
GLE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Directors

24 Sep 2019 07:00

RNS Number : 3744N
MJ Gleeson PLC
24 September 2019
 

MJ Gleeson plc

(GLE.L)

 

For immediate release

Re Directorate

The Board of MJ Gleeson plc ("Gleeson", "the Group" or "the Company") announces that Andrew Coppel CBE and Fiona Goldsmith will join the Board as non-executive Directors with effect from 1st October 2019.

Andrew Coppel, an FCA, is currently (since 2016) Chairman of Dolphin Capital Investors, the AIM-listed real estate investment company focusing on the residential resort sector in emerging markets. Following on from a diverse executive career, including roles at Queens Moat Houses (CEO: 1993-2003) and De Vere Group (CEO 2010-2015), Andrew has undertaken a number of non-executive positions including Crest Nicholson (2009-2011). Following seven years as Chairman of Tourism Ireland (2000-2007) Andrew was appointed CBE in 2008 for services to Irish Tourism.

Fiona Goldsmith is currently (since 2018) non-executive Director and Chair of the Audit Committee at Safestyle UK plc and was formerly (2008-2018) non-executive Director and Chair of the Audit Committee at Walker Greenbank plc. Following qualification at KPMG, Fiona spent a period at the firm (1989-1998) focused on the transport and leisure sectors in various roles.  She then moved on to First Choice Holidays plc (1998-2003), where she was latterly European Financial Director, then to Land Securities Group plc (2004-2008) where she was Finance Director, Land Securities Trillium. Fiona is an FCA.

Following an appropriate transition period, Ross Ancell and Colin Dearlove, will step down from the Board, having served thirteen years and twelve years respectively. It is expected that Andrew will succeed Ross as Chair of the Remuneration Committee and that Fiona will succeed Colin as Chair of the Audit Committee.

 

Dermot Gleeson, Chairman, commented:

"We are delighted to welcome Andrew and Fiona to the Board. They will bring a wealth of experience with them and we very much look forward to working with them.

"On behalf of the Board, I would like to express our very sincere thanks to Ross and Colin. We have benefited hugely from their tremendous commitment to the business and their consistently wise counsel."

ENDS

Notes:

No further information is required to be disclosed pursuant to LR 9.6.13 R.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person responsible for arranging the release of this announcement on behalf of the Company is Stefan Allanson, Chief Financial Officer.

LEI: 21380064K7N2W7FD6434

Enquiries:

Instinctif Partners

Tel: +44 207 457 2020

Mark Garraway

James Gray

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOACKNDQKBKBCCB
Date   Source Headline
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments
12th Dec 20227:00 amRNSAppointment of Managing Director of Gleeson Land
8th Dec 20221:26 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:46 pmRNSDirector/PDMR Shareholding
18th Nov 20221:05 pmRNSResult of AGM
18th Nov 20227:00 amRNSAGM Trading Update
8th Nov 202212:34 pmRNSDirector/PDMR Shareholding
4th Nov 20221:31 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRe: Financial Calendar
31st Oct 20227:00 amRNSTotal Voting Rights
21st Oct 20224:21 pmRNSPerformance Share Plan award to Directors & PDMRs
20th Oct 20227:00 amRNSNotice of AGM
12th Oct 20227:00 amRNSRe Directorate
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20221:25 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSRe Directorate External Appointments
5th Oct 20224:15 pmRNSExercise of Options & PDMR Dealing
3rd Oct 202211:55 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSFinal Results
7th Sep 20229:50 amRNSDirector/PDMR Shareholding
31st Aug 20227:00 amRNSTotal Voting Rights
9th Aug 20229:41 amRNSDirector/PDMR Shareholding
1st Aug 202211:28 amRNSNotification of Transaction by Directors/PCA
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20222:26 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSTrading Update & Notice of Results
7th Jul 20229:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.